A phase IIa/b, randomised, double-blind, placebo-controlled, single-site, parallel group clinical trial to examine cannabidiol (CBD) as a pharmacological treatment for cannabis dependence in a young cannabis dependent population.
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Cannabidiol (Primary)
- Indications Drug dependence
- Focus Proof of concept; Therapeutic Use
- 02 Jul 2014 New trial record